The latest Microwave vs Radiofrequency Ablation (RFA) research suggests that RFA may be more effective at longer follow-up periods. We’ve gathered the insights you need to better understand the difference between these two treatment modalities. Learn more about the differences between RFA and Microwave Ablation for thyroid nodules below.
Microwave Ablation is not the same as Radiofrequency Ablation, though they share similarities. Both procedures aim to destroy targeted tissue, which the body eliminates as waste. However, microwave ablation delivers energy at a higher frequency than RFA via direct oscillation of electromagnetic energy. In contrast, RFA uses an oscillating current on the radiofrequency spectrum.
As a result, microwave thyroid ablation offers higher power and a larger ablation zone compared to RFA. While advantageous for treating larger organs like the liver, MWA’s intensity can pose challenges for structures like the thyroid.
More precise marginal venous ablation is crucial for effective volume reduction. Likewise, precision is essential for preventing marginal regrowth. A higher level of accuracy can be found using the radiofrequency ablation procedure, ideal for smaller, more delicate structures such as the thyroid.
RFA is often considered a safer and more precise option compared to microwave thyroid ablation. The lower power of ablation reduces the risk of complications. As a result, practitioners newer to minimally invasive thyroid treatment learn faster and achieve consistently positive outcomes.
The most recent research from Baek et al. and Zufry et al. revealed the following insights about RFA and microwave ablation for the thyroid:
RFA demonstrated a significantly higher VRR than MWA in clinicians with less than 10 years of experience
Voice changes are less frequent with RFA than with MWA, probably due to higher ablation power with microwave ablation.
MWA often leads to carbonization in ablated lesions due to temperatures over 150 °C, which is less common in RFA where temperatures do not exceed 110 °C
This is the perfect time to pursue clinical training and implement this efficacious modality into your practice.
Research suggests that thyroid RFA patients consistently experience more favorable long-term outcomes compared to MWA patients. Lower energy delivery and more predictable ablation margins make it safer to treat delicate thyroid nodules.
Electrodes used in the RFA procedure are smaller, thinner, and more agile than microwave antennas. As a result, they do not require an incision, leading to more comfortable care and efficient treatment.
Ultimately, RFA patients have lower symptom and cosmetic scores when compared to MWA patients. They have faster treatment times and require less follow-up care compared to patients treated via MWA or surgery.
Are you interested in offering your patients the most effective long-term solution for the reduction of benign thyroid nodules? Connect with us to discuss your next steps in implementing RFA in your clinical practice.
Intended Use
The VIVA combo RF System is intended for use in percutaneous and intraoperative coagulation and ablation of tissue.
Star/VIVA RF Electrode is intended for use in percutaneous and intraoperative coagulation and ablation of tissue.
The ELRA Electrode is a radiofrequency (RF) catheter which provides bipolar energy to perform partial or complete ablation of tissue in the pancreatic and biliary tracts.
Quick links
Copyright © 2025 STARmed America. All Rights Reserved. Product names are trademarks or registered trademarks of STARmed America or their respective owners.
